Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim R Cressey

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 19, 2006
Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an updateTim R Cressey, Marc Lallemant
The Lancet. HIV|April 15, 2024
Expanding options of child-friendly, single-tablet regimens for young children with HIVTim R Cressey, Anna Turkova
Pharmacogenomics|December 19, 2009
Pharmacogenomics and the prevention of mother-to-child transmission of HIVTim R Cressey, Marc Lallemant
Pharmacogenomics|October 13, 2012
Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeedingAdeniyi Olagunju, Andrew Owen, Tim R Cressey
Clinical Pharmacokinetics|September 29, 2012
Pharmacokinetic optimization of antiretroviral therapy in pregnancyKajal Buckoreelall, Tim R Cressey, Jennifer R King
The Pediatric Infectious Disease Journal|January 2, 2007
Efficacy and plasma concentrations of indinavir when boosted with ritonavir in human immunodeficiency virus-infected Thai childrenNottasorn Plipat, Tim R Cressey, Nirun Vanprapar, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 2, 2007
Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settingsTim R Cressey, Nottasorn Plipat, Federica Fregonese, et al.
AIDS (London, England)|June 5, 2014
Does pregnancy affect the pharmacokinetics of efavirenz?Andrew Hill, Nathan Ford, Marta Boffito, et al.
Antiviral Therapy|May 29, 2009
Plasma efavirenz concentrations and the association with CYP2B6-516G >T polymorphism in HIV-infected Thai childrenThanyawee Puthanakit, Pranoot Tanpaiboon, Linda Aurpibul, et al.
Analytica Chimica Acta|May 27, 2019
Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assayWeeraya Thongkum, Sudarat Hadpech, Yardpiroon Tawon, et al.
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 19, 2006
Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an updateTim R Cressey, Marc Lallemant
The Lancet. HIV|April 15, 2024
Expanding options of child-friendly, single-tablet regimens for young children with HIVTim R Cressey, Anna Turkova
Pharmacogenomics|December 19, 2009
Pharmacogenomics and the prevention of mother-to-child transmission of HIVTim R Cressey, Marc Lallemant
Pharmacogenomics|October 13, 2012
Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeedingAdeniyi Olagunju, Andrew Owen, Tim R Cressey
Clinical Pharmacokinetics|September 29, 2012
Pharmacokinetic optimization of antiretroviral therapy in pregnancyKajal Buckoreelall, Tim R Cressey, Jennifer R King
The Pediatric Infectious Disease Journal|January 2, 2007
Efficacy and plasma concentrations of indinavir when boosted with ritonavir in human immunodeficiency virus-infected Thai childrenNottasorn Plipat, Tim R Cressey, Nirun Vanprapar, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 2, 2007
Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settingsTim R Cressey, Nottasorn Plipat, Federica Fregonese, et al.
AIDS (London, England)|June 5, 2014
Does pregnancy affect the pharmacokinetics of efavirenz?Andrew Hill, Nathan Ford, Marta Boffito, et al.
Antiviral Therapy|May 29, 2009
Plasma efavirenz concentrations and the association with CYP2B6-516G >T polymorphism in HIV-infected Thai childrenThanyawee Puthanakit, Pranoot Tanpaiboon, Linda Aurpibul, et al.
Analytica Chimica Acta|May 27, 2019
Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assayWeeraya Thongkum, Sudarat Hadpech, Yardpiroon Tawon, et al.
Pageof 17